suPAR Michigan M2C2 Heterogeneity Validation Cohort Study

Completed

Conditions studied: COVID-19, Severe Respiratory Distress Syndrome, Acute Respiratory Distress Syndrome

In brief

This is a retrospective, non interventional cohort study using stored plasma samples from appoximately 300 adults hospitalized with confirmed COVID 19. Baseline suPAR measured using the suPARnostic TurbiLatex assay on the Roche cobas c501.

Key facts

Study ID

NCT07466524

Run by

ViroGates A/S

People needed

367

Starts

2020-02-01

Expected to finish

2022-10-19

Last updated by the study team

2026-03-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Michigan state university, Department of Biostatistics — Ann Arbor, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.